News
Monday, Citi analyst Ariel Rosa upgraded Union Pacific shares to Buy from Hold after getting more clarity on railroad mergers ...
MarketBeat on MSN
Rezolute Stock: FDA Fast Track Fuels 2025 Breakout
Rezolute, Inc.’s (NASDAQ: RZLT) stock price is steadily moving higher in 2025 and is expected to continue its run because of ...
On Tuesday, UBS analyst Christopher Schoell downgraded AST SpaceMobile stock from Buy to Neutral and lowered the price target ...
With shares up 222% in 36 months, Carnival is obviously on the right track. But with the stock still 56% below its record ...
Read here for an update on Ariel Investments’ Q2 2025 portfolio updates, top holdings, and outperformance insights.
CRISPR Therapeutics AG is a long-term buy despite slow Casgevy uptake. Click for my updated look at CRSP earnings and the ...
The US has recently reversed a ban on Nvidia that restricted them from sending its export control-compliant chip known as the H20 to China. However, not everyone agrees with the decision. According to ...
The company is still impressing investors and professional DLocal-watchers several weeks after its latest quarterly earnings ...
Baird's Mark Altschwager made the move Wednesday morning, changing his fair value assessment to $17 per share from his previous $15. That doesn't quite make him a Kohl's bull, however, as he left his ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results